Header cover image

Indian Pharmaceuticals & Biotech Low-Risk Leaders

Results

3

0 new
Every great portfolio needs a good foundation. Our selection of stocks can help you lower your risk without sacrificing your returns. Invest in the market's most resilient companies with strong balance sheets and the lowest risk scores in our model.

3 companies

Granules India

Market Cap: ₹206.5b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.

532482

₹833.15

7D

9.1%

1Y

69.1%

Shilpa Medicare

Market Cap: ₹119.0b

Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.

530549

₹608.55

7D

6.5%

1Y

35.4%

Caplin Point Laboratories

Market Cap: ₹192.7b

Engages in the development, production, marketing, and export of generic formulations and branded products in India.

524742

₹2,535.35

7D

1.1%

1Y

25.7%